María Ángeles Martínez-Zamora

Dr. María Ángeles Martínez-Zamora


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
AAAna María Alcalde
Ana María Alcalde
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora
MGMeritxell Gracia
Meritxell Gracia
CRCristina Ros
Cristina Ros
MRMariona Rius
Mariona Rius
FCFrancisco Carmona
Francisco Carmona
Background The quality of life of women with deep infiltrating endometriosis (DIE) is impaired and may improve with combined oral contraceptives (COCs). Aim To compare the overall and sexual quality of life of patients diagnosed with DIE with or without associated adenomyosis (AD) with that of healthy controls and determine the influence of a COC containing 2 mg dienogest/30 μg ethinyl estradiol on these aspects. Methods We enrolled 42 women diagnosed with DIE; 31 diagnosed with DIE + AD by transvaginal ultrasound, and 39 non-AD/DIE controls. All patients were interviewed regarding pain symptoms (dysmenorrhea, dyspareunia, dyschezia, and dysuria), heavy menstrual bleeding using the Pictorial Blood Loss Assessment Chart, quality of life using the Short Form-36 questionnaire (SF-36), and sexual quality of life using the Sexual Quality of Life-Female questionnaire (SQOL-F) and the Brief Profile of Female Sexual Function (B-PFSF) before starting COCs and after 12 months of treatment. Outcomes There was significant improvement in overall and sexual quality of life after treatment in DIE and DIE + AD patients. Results Non-AD/DIE controls showed significantly higher scores in the B-PFSF, the SQOL-F and the SF-36 questionnaires (P < .05) at baseline versus the other groups. DIE + AD patients showed poorer quality of sexual life and greater intensity in pain symptoms compared with DIE patients. After 12 months of treatment, there was a significant improvement in overall and sexual quality of life in the DIE and DIE + AD groups, with improvement in sexual quality of life being slightly greater in DIE + AD patients compared with DIE patients. Pain symptoms also decreased in both groups. Clinical Implications Patients with DIE + AD showed greater impairment in overall and sexual quality of life compared with patients with isolated DIE which seems to improve with a COC containing 2 mg dienogest/30 μg ethinyl estradiol. Strengths & limitations Strengths include the long-term follow up, assessment of the impact of two associated conditions, and administration of the same COC in all patients. Limitations include the relatively small sample size, and the fact that we did not assess the effectiveness of a flexible extended COC regimen containing 2 mg dienogest/30 μg ethinyl estradiol since the groups were different at baseline. Conclusion Patients diagnosed with DIE with or without AD have a decreased quality of life which may improve with a COC containing 2 mg dienogest/30 μg ethinyl estradiol. Further research is needed to confirm our results. Alcalde AM, Martínez-Zamora MÁ, Gracia M, et al. Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study. J Sex Med 2022;19:311–318.

1 January 2019 in Reproductive Sciences
Verified
Journal Article
Closed access
JMJordina Munrós
Jordina Munrós
DTDolors Tàssies
Dolors Tàssies
JRJoan Carles Reverter
Joan Carles Reverter
LMLidia Martin
Lidia Martin
APAmelia Pérez
Amelia Pérez
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora

12 November 2021 in Journal of Women's Health
Verified
Journal Article
Closed access
AAAna María Alcalde
Ana María Alcalde
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora
MGMeritxell Gracia
Meritxell Gracia
CRCristina Ros
Cristina Ros
MRMariona Rius
Mariona Rius
FCFrancisco Carmona
Francisco Carmona
Background: Quality of life in adenomyosis (AD) patients has been poorly investigated. Previous data suggest that AD has negative impact on the quality of life in these women. Materials and Methods: From September 2018 to December 2019, all consecutive female premenopausal patients aged ≥18 years diagnosed with AD by transvaginal ultrasound (TVU) were invited to participate in a comparative cross-sectional study. The Short Form-36-item (SF-36) health questionnaire and the Hospital Anxiety and Depression Scale (HADS) were administered. Work productivity and activity impairment were assessed using the Work Productivity and Activity Impairment Questionnaire: General Health version (WPAI:GH). Data obtained from these patients were compared with women with normal-appearing myometrium in the TVU recruited during routine gynecological visits. The study was approved by the Clinical Research Ethics Committee of the Hospital Clinic (reference HCB/2018/0919). Results: One hundred three patients with AD and 214 without AD were analyzed. Patients with AD compared to those without AD showed significantly lower scores in all domains of the SF-36 questionnaire and mean (SD) higher scores in the HADS questionnaire for anxiety (10.06 [3.04] vs. 6.92 [2.98], p < 0.001) and depression (6.39 [3.89] vs. 2.74 [2.01], p < 0.002). Significant differences ( p < 0.001) were also found for the percentages of absenteeism (12.2% vs. 1.1%), presenteeism (31.1% vs. 11.4%), overall work productivity loss (38.2% vs. 12.4%), and activity impairment (55.7% vs. 9.9%). The presence of AD was associated with higher yearly estimated indirect costs of €5161.32 (€7928.0 vs. €2460.8, p < 0.001). Conclusions: AD negatively affects women's health-related quality of life, psychological health, and work productivity, with impairment at work and daily activities, and higher risk for anxiety and depression.

4 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PTPilar Carrillo Torres
Pilar Carrillo Torres
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora
CRCristina Ros
Cristina Ros
MRMariona Rius
Mariona Rius
EMEduard Mensión
Eduard Mensión
FCFrancisco Carmona
Francisco Carmona
Nowadays, combined oral contraceptives (COCs) are successfully employed for the treatment of endometriosis (END) and adenomyosis (AD) in a large proportion of patients. However, literature focusing on the clinical and sonographic response to treatment in the long-term follow-up of patients with deep endometriosis (DE) and AD is scarce. The aim of this study was to evaluate the changes in the symptoms and the sonographic exams at 12 and 24 months of follow-up in patients who had received a flexible extended COC regimen containing 2 mg of dienogest/30 μg ethinyl estradiol. This prospective, longitudinal, observational study included women diagnosed with DE and AD presenting no surgical indication and were candidates to treatment with COCs. The presence and severity of dysmenorrhea, non-menstrual pelvic pain, deep dyspareunia, dyschezia and dysuria were evaluated using the Numerical Rating Scale (NRS) at baseline, and at 12 and 24 months of treatment. Transvaginal ultrasound was also performed at these check points searching for criteria of AD and reporting the size of the DE nodules and ovarian endometriomas (OE). Sixty-four patients were included. A significant decrease in the number of patients with severe dysmenorrhea and non-menstrual pelvic pain was reported during follow-up. The mean NRS score for dysmenorrhea, non-menstrual pelvic pain, deep dyspareunia, dyschezia and dysuria was also significantly lower at follow-up. There was a significant reduction in the sonographic number and type of AD criteria during follow-up after treatment. Similarly, a significant decrease in the size of OE and uterosacral ligament involvement in DE was observed at the 12-month follow-up, with a further, albeit not statistically significant, decrease in the 12- to 24-month follow-up. Additionally, torus and rectosigmoid DE decreased in size, although the reduction was not statistically significant at any study point. This prospective study suggests a clinical and sonographic improvement after a flexible extended COC regimen in DE and AD patients, which was significant at 12 months of follow-up. The improvement was more evident in AD and OEs compared with DE. Further research with a longer follow-up, larger sample size and comparison with other treatments is needed.

1 November 2021 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Open access
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora
JCJosé Luis Coloma
José Luis Coloma
MGMeritxell Gracia
Meritxell Gracia
MRMariona Rius
Mariona Rius
CCCamil Castelo-Branco
Camil Castelo-Branco
FCFrancisco Carmona
Francisco Carmona
We performed a long-term follow-up to quantify the impairment of sexual quality of life (SQL) and health-related quality of life (HRQL) in sexually active women following laparoscopic excision of deep infiltrating endometriosis (DIE). Prospective case-control study. Hospital Clinic of Barcelona. 200 patients were divided into two groups: 129 premenopausal women with DIE (DIE group) and 64 healthy women who underwent tubal ligation (C group). All patients underwent laparoscopic surgery: laparoscopic endometriosis surgery in the DIE group and laparoscopic tubal ligation in the C group. All women were followed for at least 36 months and answered the Medical Outcomes Study 36-Item Short Form (SF-36) questionnaire to assess their HRQL and 3 self-administered questionnaires that evaluate different aspects of SQL: the generic Sexual Quality of Life-Female (SQOL-F), the Female Sexual Distress Scale (FSDS) to evaluate "sexually related distress" and The Brief Profile of Female Sexual Function (B-PFSF) to screen hypoactive sexual desire disorder (HSDD). DIE patients and controls answered the four questionnaires before surgery and DIE patients also completed the questionnaires at 6 and 36 months after surgery. Comparison of patients and controls before surgery showed a statistically significant impairment of SQL and HRQL among DIE patients. Statistically significant improvement of SQL and HRQL was observed in the DIE group six months after surgery, achieving similar scores to the C group. Evaluation 36 months after surgery showed better SQL and HRQL compared with presurgical SQL in the DIE group, with a slight reduction compared with the 6-month evaluation. SQL and HRQL improved in DIE patients undergoing complete laparoscopic endometriosis resection and were comparable to healthy women at 6 months after surgery, showing a slight reduction at 36 months of follow-up.

11 April 2019 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
JCJose Luis Coloma
Jose Luis Coloma
MMMaría Ángeles Martínez-Zamora
María Ángeles Martínez-Zamora
ACAntonio Collado
Antonio Collado
MGMeritxell Gràcia
Meritxell Gràcia
MRMariona Rius
Mariona Rius
FCFrancisco Carmona
Francisco Carmona